Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.40
+0.14 (+0.55%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
31
32
Next >
Duchenne Muscular Dystrophy Market expected to rise | Companies – Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, Pfizer, Santhera Pharmaceuticals/ReveraGen BioPharma, Taiho Pharmaceutical
June 27, 2023
Via
AB Newswire
Pfizer Inc. (NYSE: PFE) is One of Monday Morning’s Most Active Stocks
June 26, 2023
Via
Investor Brand Network
Exposures
COVID-19
Multiple myeloma Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Novartis, AbbVie, Pfizer, Alliance Foundation Trials, LLC, Celgene
June 26, 2023
Via
AB Newswire
Exposures
Product Safety
Prader-Willi Syndrome Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies | Companies – Soleno Therapeutics, Levo Therapeutics, Pfizer, Novo Nordisk
June 26, 2023
Via
AB Newswire
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials
June 26, 2023
ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t
Via
MarketBeat
Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
June 26, 2023
From
Pfizer Inc.
Via
Business Wire
Leiomyosarcoma Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies |Companies – Pfizer, PTC Therapeutics, GlaxoSmithKline, AstraZeneca, Merck
June 26, 2023
Via
AB Newswire
Neuroendocrine Tumor Pipeline Drugs 2023 (Updated), FDA Approvals, Clinical Trials, MOA, ROA | MedImmune, Genentech, Merck & Co, Pfizer, Takeda Oncology, Hutchison MediPharma, and others
June 26, 2023
Via
AB Newswire
Exposures
Product Safety
FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
June 23, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Declares Third-Quarter 2023 Dividend
June 22, 2023
From
Pfizer Inc.
Via
Business Wire
Cerebral Aneurysm Treatment Market, Epidemiology, Therapies, FDA Approval, Companies and Market forecast by DelveInsight | Biogen, Pfizer, Roche, Merck, Novartis, Sanofi, Teva Pharmaceutical
June 21, 2023
Via
AB Newswire
Exposures
Product Safety
Refractory Acute Myeloid Leukemia Market to witness growth by 2032, estimates DelveInsight | Pfizer, Merck, Novartis, Astellas, Amgen, Janssen, Kartos, Cullinan Oncology, Meryx
June 21, 2023
Via
AB Newswire
Smartsheet Investors’ Hasty Exit Can Be Your Gain
June 21, 2023
Enterprise workflow collaboration and automation software maker Smartsheet Inc. (NASDAQ: SMAR) shares plummeted over 20% due to its fiscal Q1 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Eosinophilic Gastroenteritis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Novartis, Allakos, AstraZeneca, Pfizer, Regeneron, Celgene
June 21, 2023
Via
AB Newswire
Meniere’s Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies|Companies-Otonomy Inc, Solvay Pharmaceuticals, Pfizer, Abbott, Synphora AB
June 21, 2023
Via
AB Newswire
Pfizer’s TALZENNA® in Combination with XTANDI® Receives U.S. FDA Approval
June 20, 2023
From
Pfizer Inc.
Via
Business Wire
Vitiligo Market expected to rise | Companies – Incyte Corporation, Amgen, Boston Pharmaceuticals, Arcutis Biotherapeutics, Pfizer, Dermavant Sciences, Clinuvel Pharmaceuticals, Celgene
June 20, 2023
Via
AB Newswire
Respiratory Syncytial Virus Market expected to rise | Companies – Bavarian Nordic, GlaxoSmithKline, Janssen, Sanofi, AstraZeneca, Moderna, ReViral, Pfizer, expected to drive market
June 20, 2023
Via
AB Newswire
Adeno-Associated Virus (AAV) Vector Based Gene Therapy Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Pfizer, uniQure, CSL Behring, NightstaRx
June 20, 2023
Via
AB Newswire
Pfizer Invites Public to View and Listen to Webcast of August 1 Conference Call with Analysts
June 20, 2023
From
Pfizer Inc.
Via
Business Wire
Blepharitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Allergan Plc, Bausch Health , Novartis, Pfizer, AxeroVision
June 20, 2023
Via
AB Newswire
Chronic Kidney Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Pfizer, Novotech, Vifor Pharma, Takeda, CinCor Pharma, Galderma R&D, Abbott
June 20, 2023
Via
AB Newswire
Atopic Dermatitis Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies, Patient Pool, and Companies DelveInsight | Sanofi, Regeneron, Pfizer, Japan Tobacco, Torii Pharmaceutical
June 20, 2023
Via
AB Newswire
Exposures
Product Safety
Alopecia Areata Market Analysis, Growth Opportunities, Clinical Trials Assessment, Emerging Therapies, Leading Companies, and Epidemiology Forecast | Arcutis, Concert Pharmaceutical, HCW Biologics
June 20, 2023
Via
AB Newswire
Biologics and Biosimilars Market Is Touching New Level – A Comprehensive Study with Key Players Amgen, AbbVie, Sanofi-Aventis
June 19, 2023
Biologics and Biosimilar Market Size, Status and Forecast 2028
Via
SBWire
Topics
Intellectual Property
Exposures
Intellectual Property
ABSSSI Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Market Forecast by DelveInsight| Merck, Pfizer, Paratek Pharmaceutical, Melinta Therapeutics, Allergan, Novexel
June 16, 2023
Via
AB Newswire
Exposures
Product Safety
Complicated Urinary Tract Infection (cUTI) Market to Witness Growth by 2032, Estimates DelveInsight| Meiji Seika Pharma, Pfizer, Novartis, Spero Therapeutics, Tetraphase Pharmaceuticals, Wockhardt
June 16, 2023
Via
AB Newswire
Postherpetic Neuralgia Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Pfizer, Winston Laboratories, Xenon Pharma, Bausch Health, Shanghai SIMR
June 16, 2023
Via
AB Newswire
Neuroendocrine Tumors Pipeline, Clinical Trials, and Emerging Drugs (2023) | Companies – MedImmune, Genentech, Merck & Co, Pfizer, Takeda Oncology, Hutchison MediPharma, and Others
June 16, 2023
Via
AB Newswire
Bullish or Bearish? Vetting Animal Health Care Stocks
June 16, 2023
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up.
Via
MarketBeat
Topics
ETFs
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.